Hui-Yen Chuang
-
- Cancer, Lipids, and Metabolism 4
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3
- Immune cells in cancer 3
-
- CAR-T cell therapy research 3
-
- RNA Interference and Gene Delivery 3
- Peroxisome Proliferator-Activated Receptors 3
- Extracellular vesicles in disease 2
- Co-authors
- Jeng‐Jong HwangYa-Fang ChangSanjiv S. GambhirRen-Shyan LiuFei‐Ting HsuGayatri GowrishankarAmin AalipourCorinne Beinat
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Hui-Yen Chuang
17 papers receiving 463 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 159
- Molecular Medicine 26
- Immunology 109
- Oncology 124
- Molecular Biology 246
Countries citing papers authored by Hui-Yen Chuang
This map shows the geographic impact of Hui-Yen Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Yen Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Yen Chuang more than expected).
Fields of papers citing papers by Hui-Yen Chuang
This network shows the impact of papers produced by Hui-Yen Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Yen Chuang. The network helps show where Hui-Yen Chuang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui-Yen Chuang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 13 | |
| 7 | 2020 | 6 | |
| 8 | 2019 | 61 | |
| 9 | 2019 | 110 | |
| 10 | 2017 | 12 | |
| 11 | 2016 | 5 | |
| 12 | 2016 | 26 | |
| 13 | 2016 | 28 | |
| 14 | 2015 | 25 | |
| 15 | 2014 | 32 | |
| 16 | 2013 | 16 | |
| 17 | 2011 | 51 | |
| 18 | 2011 | 70 |
About Hui-Yen Chuang
Hui-Yen Chuang is a scholar working on Cancer Research, Immunology and Oncology, having authored 18 papers that have together received 466 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (4 papers), Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers), RNA Interference and Gene Delivery (3 papers), Immune Cell Function and Interaction (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Immune cells in cancer (3 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (159 citations), Molecular Medicine (26 citations) and Immunology (109 citations). Hui-Yen Chuang has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Jeng‐Jong Hwang, Ya-Fang Chang, Sanjiv S. Gambhir, Ren-Shyan Liu, Fei‐Ting Hsu, Gayatri Gowrishankar, Amin Aalipour, Corinne Beinat, Elise Robinson and Surya Murty. Their work appears in journals such as Nano Letters, Nature Biotechnology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.